Myriad Stocks Rise with FDA Approval

For the next 12 months TipRanks estimates shares of Myriad could increase to as high as $45.00 or as low...

Top Genetics Stocks on the NASDAQ in 2017

Which genetics companies came out on top on the NASDAQ in 2017? Read on to find out.

Myriad Genetics Launches Collaboration With BeiGene

Myriad Genetics announced a diagnostic development collaboration with BeiGene a company developing molecularly-targeted and immuno-oncology drugs for the treatment of...